UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immune reconstitution inflammatory syndrome in non‐HIV immunosuppressed patients

Journal of dermatology, 2018-01, Vol.45 (1), p.3-9

2018

Volltextzugriff (PDF)

Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP

Journal of dermatology, 2018-11, Vol.45 (11), p.1235-1270

2018

Volltextzugriff (PDF)

Role of pro‐inflammatory cytokines in the pathophysiology of herpes simplex virus superinfection in Darier’s disease

Journal of dermatology, 2021-10, Vol.48 (10), p.1607-1611

2021

Volltextzugriff (PDF)

Risk of Progression to Autoimmune Disease in Severe Drug Eruption: Risk Factors and the Factor-Guided Stratification

Journal of investigative dermatology, 2022-03, Vol.142 (3), p.960-968.e9

2022

Volltextzugriff (PDF)

Detection of multinucleated giant cells in differentiated keratinocytes with herpes simplex virus and varicella zoster virus infections by modified Tzanck smear method

Journal of dermatology, 2021-01, Vol.48 (1), p.21-27

2021

Volltextzugriff (PDF)

SARS‐CoV‐2 vaccine‐triggered conversion from systemic lupus erythematosus (SLE) to bullous SLE and dipeptidyl peptidase 4 inhibitors‐associated bullous pemphigoid

Journal of dermatology, 2023-02, Vol.50 (2), p.162-165

2023

Volltextzugriff (PDF)

Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)

Journal of dermatology, 2019-12, Vol.46 (12), p.1102-1135

2019

Volltextzugriff (PDF)

Clinical features of dipeptidyl peptidase‐4 inhibitor‐associated bullous pemphigoid in Japan: A nationwide retrospective observational study

Journal of dermatology, 2022-07, Vol.49 (7), p.697-702

2022

Volltextzugriff (PDF)

Herpes simplex virus-induced murine dry skin model through sweating disturbance

Journal of dermatological science, 2022-09, Vol.107 (3), p.151-159

2022

Volltextzugriff (PDF)

Sweat is a most efficient natural moisturizer providing protective immunity at points of allergen entry

Allergology International, 2018-10, Vol.67 (4), p.442-447

2018

Volltextzugriff (PDF)

Systemic capillary leak syndrome triggered by anti‐programmed death 1 checkpoint inhibitor in psoriasis

Journal of dermatology, 2020-11, Vol.47 (11), p.1322-1325

2020

Volltextzugriff (PDF)

Cell-to-cell transmission of HSV-1 in differentiated keratinocytes promotes multinucleated giant cell formation

Journal of dermatological science, 2019-01, Vol.93 (1), p.14-23

2019

Volltextzugriff (PDF)

Cathelicidin Antimicrobial Peptide LL-37 in Psoriasis Enables Keratinocyte Reactivity against TLR9 Ligands

Journal of investigative dermatology, 2012-01, Vol.132 (1), p.135-143

2012

Volltextzugriff (PDF)

Anti-Cytomegalovirus Therapy: Whether and When to Initiate, Those Are the Questions

Pharmaceuticals (Basel, Switzerland), 2022-06, Vol.15 (7), p.797

2022

Volltextzugriff (PDF)

A multicenter, open-label, uncontrolled, single-arm phase 2 study of tirabrutinib, an oral Bruton’s tyrosine kinase inhibitor, in pemphigus

Journal of dermatological science, 2021-09, Vol.103 (3), p.135-142

2021

Volltextzugriff (PDF)

Biomarkers for predicting immune reconstitution inflammatory syndrome in dipeptidyl peptidase‐4 inhibitor‐associated bullous pemphigoid: A retrospective observational study with a case series

JEADV clinical practice, 2024-03, Vol.3 (1), p.226-232

2024

Volltextzugriff (PDF)

Japanese guidelines for the management of pemphigus

Journal of dermatology, 2014-06, Vol.41 (6), p.471-486

2014

Volltextzugriff (PDF)

What's new in i.v. immunoglobulin therapy and pemphigus: High-dose i.v. immunoglobulin therapy and its mode of action for treatment of pemphigus

Journal of dermatology, 2010-03, Vol.37 (3), p.239-245

AOYAMA, Yumi

2010

Volltextzugriff (PDF)

Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations

JAMA dermatology (Chicago, Ill.), 2017-01, Vol.153 (1), p.66

2017

Volltextzugriff (PDF)

Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia

Blood, 2022-08, Vol.140 (8), p.875-888

2022

Volltextzugriff (PDF)

Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open‐label, single‐arm, phase 1/2 study on 10 Japanese patients

Journal of dermatology, 2019-02, Vol.46 (2), p.124-130

2019

Volltextzugriff (PDF)

Adrenal Insufficiency Secondary to Abrupt Dose Reduction of Topical Corticosteroid Therapy after Starting Brodalumab for Psoriasis: A Case Report

Case reports in dermatology, 2022-03, Vol.14 (1), p.77-83

2022

Volltextzugriff (PDF)

Prolonged shedding of SARS-CoV-2 in COVID-19 infected hemodialysis patients

Therapeutic apheresis and dialysis, 2021-06, Vol.25 (3), p.356-358

2021

Volltextzugriff (PDF)

BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state

Nature communications, 2023-12, Vol.14 (1), p.8372-22, Article 8372

2023

Volltextzugriff (PDF)

Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease

Internal Medicine, 2020/04/01, Vol.59(7), pp.971-976

2020

Volltextzugriff (PDF)

1 – 25 von 325

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(275)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Immune reconstitution inflammatory syndrome in non‐HIV immunosuppressed patients

Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP

Role of pro‐inflammatory cytokines in the pathophysiology of herpes simplex virus superinfection in Darier’s disease

Risk of Progression to Autoimmune Disease in Severe Drug Eruption: Risk Factors and the Factor-Guided Stratification

Detection of multinucleated giant cells in differentiated keratinocytes with herpes simplex virus and varicella zoster virus infections by modified Tzanck smear method

SARS‐CoV‐2 vaccine‐triggered conversion from systemic lupus erythematosus (SLE) to bullous SLE and dipeptidyl peptidase 4 inhibitors‐associated bullous pemphigoid

Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)

Clinical features of dipeptidyl peptidase‐4 inhibitor‐associated bullous pemphigoid in Japan: A nationwide retrospective observational study

Herpes simplex virus-induced murine dry skin model through sweating disturbance

Sweat is a most efficient natural moisturizer providing protective immunity at points of allergen entry

Systemic capillary leak syndrome triggered by anti‐programmed death 1 checkpoint inhibitor in psoriasis

Cell-to-cell transmission of HSV-1 in differentiated keratinocytes promotes multinucleated giant cell formation

Cathelicidin Antimicrobial Peptide LL-37 in Psoriasis Enables Keratinocyte Reactivity against TLR9 Ligands

Anti-Cytomegalovirus Therapy: Whether and When to Initiate, Those Are the Questions

A multicenter, open-label, uncontrolled, single-arm phase 2 study of tirabrutinib, an oral Bruton’s tyrosine kinase inhibitor, in pemphigus

Biomarkers for predicting immune reconstitution inflammatory syndrome in dipeptidyl peptidase‐4 inhibitor‐associated bullous pemphigoid: A retrospective observational study with a case series

Japanese guidelines for the management of pemphigus

What's new in i.v. immunoglobulin therapy and pemphigus: High-dose i.v. immunoglobulin therapy and its mode of action for treatment of pemphigus

Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations

Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia

Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open‐label, single‐arm, phase 1/2 study on 10 Japanese patients

Adrenal Insufficiency Secondary to Abrupt Dose Reduction of Topical Corticosteroid Therapy after Starting Brodalumab for Psoriasis: A Case Report

Prolonged shedding of SARS-CoV-2 in COVID-19 infected hemodialysis patients

BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state

Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease

Suchergebnisse filtern